Citigroup raised its rating on the stock of Lexicon Pharmaceuticals.
3 reports, 2 independent
Updated Sep 4
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup raised its rating on the stock of Lexicon Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Lexicon Pharmaceuticals
biopharmaceutical company
Nothing else this week.
Related events
- Citigroup raised shares to a buy rating for Fisher & Paykel Healthcare.
- Citigroup reiterated a market outperform rating for KB Home.
- Citigroup raised price targets and ratings for Rayonier on September 11, 2026.
- Citigroup provided a stock rating for Altimmune, Inc.
- Penguin Solutions, Inc. stock traded on Nasdaq, with Citigroup providing rating updates and legal filings made with the SEC.